Ran Inoue

1.4k total citations
30 papers, 1.1k citations indexed

About

Ran Inoue is a scholar working on Molecular Biology, Biochemistry and Cellular and Molecular Neuroscience. According to data from OpenAlex, Ran Inoue has authored 30 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 16 papers in Biochemistry and 11 papers in Cellular and Molecular Neuroscience. Recurrent topics in Ran Inoue's work include Amino Acid Enzymes and Metabolism (16 papers), Epigenetics and DNA Methylation (11 papers) and Neuroscience and Neuropharmacology Research (10 papers). Ran Inoue is often cited by papers focused on Amino Acid Enzymes and Metabolism (16 papers), Epigenetics and DNA Methylation (11 papers) and Neuroscience and Neuropharmacology Research (10 papers). Ran Inoue collaborates with scholars based in Japan, United States and Bangladesh. Ran Inoue's co-authors include Hisashi Mori, Kenji Hashimoto, Toshio Miyawaki, Kazuhisa Hongou, Manabu Abe, Yoshimi Takata, Kenji Sakimura, Kazushi Miya, Rie Natsume and Yūkō Fujita and has published in prestigious journals such as Journal of Neuroscience, PLoS ONE and The Journal of Comparative Neurology.

In The Last Decade

Ran Inoue

30 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ran Inoue Japan 17 653 563 474 169 161 30 1.1k
Jeffrey T. Ehmsen United States 11 502 0.8× 618 1.1× 383 0.8× 106 0.6× 131 0.8× 16 946
Tommaso Nuzzo Italy 18 335 0.5× 369 0.7× 207 0.4× 144 0.9× 83 0.5× 36 688
Inmaculada M. González‐González Spain 15 158 0.2× 389 0.7× 420 0.9× 45 0.3× 27 0.2× 19 679
S. Rasika Wickramasinghe United States 5 140 0.2× 263 0.5× 298 0.6× 27 0.2× 32 0.2× 6 555
P. Shashidharan United States 25 277 0.4× 699 1.2× 1.3k 2.6× 101 0.6× 11 0.1× 34 2.1k
D. Z. Gerhart United States 8 149 0.2× 421 0.7× 273 0.6× 106 0.6× 13 0.1× 9 895
Anna Maio Italy 15 106 0.2× 198 0.4× 185 0.4× 57 0.3× 25 0.2× 45 621
Jojanneke H.J. Huck Netherlands 13 90 0.1× 361 0.6× 605 1.3× 49 0.3× 42 0.3× 15 1.3k
Carolina Maestre Spain 7 59 0.1× 760 1.3× 237 0.5× 61 0.4× 39 0.2× 8 1.1k
Shu‐Hsien Sheu United States 11 118 0.2× 567 1.0× 256 0.5× 22 0.1× 28 0.2× 15 1.1k

Countries citing papers authored by Ran Inoue

Since Specialization
Citations

This map shows the geographic impact of Ran Inoue's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ran Inoue with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ran Inoue more than expected).

Fields of papers citing papers by Ran Inoue

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ran Inoue. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ran Inoue. The network helps show where Ran Inoue may publish in the future.

Co-authorship network of co-authors of Ran Inoue

This figure shows the co-authorship network connecting the top 25 collaborators of Ran Inoue. A scholar is included among the top collaborators of Ran Inoue based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ran Inoue. Ran Inoue is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Linyu, Ayako Imai, Hironori Izumi, et al.. (2024). Differential contribution of canonical and noncanonical NLGN3 pathways to early social development and memory performance. Molecular Brain. 17(1). 16–16. 2 indexed citations
3.
Inoue, Ran, et al.. (2018). Impairment in extinction of cued fear memory in syntenin-1 knockout mice. Neurobiology of Learning and Memory. 149. 58–67. 8 indexed citations
5.
Inoue, Ran, et al.. (2018). Dissociated Role of D-Serine in Extinction During Consolidation vs. Reconsolidation of Context Conditioned Fear. Frontiers in Molecular Neuroscience. 11. 161–161. 14 indexed citations
6.
Inoue, Ran, et al.. (2018). Serine racemase deletion attenuates neurodegeneration and microvascular damage in diabetic retinopathy. PLoS ONE. 13(1). e0190864–e0190864. 20 indexed citations
7.
Yang, Zheng, Seiji Yamamoto, Yoko Ishii, et al.. (2016). Glioma-Derived Platelet-Derived Growth Factor-BB Recruits Oligodendrocyte Progenitor Cells via Platelet-Derived Growth Factor Receptor-α and Remodels Cancer Stroma. American Journal Of Pathology. 186(5). 1081–1091. 11 indexed citations
8.
Inoue, Ran, Tomoyuki Yoshida, Tetsuya Ishimoto, et al.. (2016). Novel role of serine racemase in anti-apoptosis and metabolism. Biochimica et Biophysica Acta (BBA) - General Subjects. 1861(1). 3378–3387. 7 indexed citations
9.
Takikawa, Akiko, Isao Usui, Shiho Fujisaka, et al.. (2015). Deletion of SIRT1 in myeloid cells impairs glucose metabolism with enhancing inflammatory response to adipose tissue hypoxia. Diabetology International. 7(1). 59–68. 6 indexed citations
10.
Ishii, Yoko, Takeru Hamashima, Seiji Yamamoto, et al.. (2015). PDGFRα plays a crucial role in connective tissue remodeling. Scientific Reports. 5(1). 17948–17948. 62 indexed citations
12.
Inoue, Ran, Tomokazu Ito, Kohtarou Konno, et al.. (2014). Is d-aspartate produced by glutamic-oxaloacetic transaminase-1 like 1 (Got1l1): a putative aspartate racemase?. Amino Acids. 47(1). 79–86. 31 indexed citations
13.
Horio, Mao, Tamaki Ishima, Yūkō Fujita, et al.. (2013). Decreased levels of free d-aspartic acid in the forebrain of serine racemase (Srr) knock-out mice. Neurochemistry International. 62(6). 843–847. 25 indexed citations
14.
Rosenberg, Dina, Inna Radzishevsky, Veronika N. Foltyn, et al.. (2013). Neuronal d-Serine and Glycine Release Via the Asc-1 Transporter Regulates NMDA Receptor-Dependent Synaptic Activity. Journal of Neuroscience. 33(8). 3533–3544. 181 indexed citations
15.
Horio, Mao, Yūkō Fujita, Tamaki Ishima, et al.. (2012). Role of Serine Racemase in Behavioral Sensitization in Mice after Repeated Administration of Methamphetamine. PLoS ONE. 7(4). e35494–e35494. 18 indexed citations
16.
Inoue, Ran, Yūkō Fujita, Ayumi Tanaka, et al.. (2012). Decreased susceptibility to seizures induced by pentylenetetrazole in serine racemase knockout mice. Epilepsy Research. 102(3). 180–187. 20 indexed citations
17.
Okamoto, Kousuke, Shigeki Inui, Hiroyuki Yamasaki, et al.. (2012). A Practical Estimation Method for Analyzing Adverse Drug Reactions Using Data Mining. Therapeutic Innovation & Regulatory Science. 47(2). 235–241. 1 indexed citations
18.
Horio, Mao, Yūkō Fujita, Tamaki Ishima, et al.. (2011). Levels of d-serine in the brain and peripheral organs of serine racemase (Srr) knock-out mice. Neurochemistry International. 59(6). 853–859. 82 indexed citations
19.
Mori, Hisashi & Ran Inoue. (2010). Serine Racemase Knockout Mice. Chemistry & Biodiversity. 7(6). 1573–1578. 24 indexed citations
20.
Miya, Kazushi, Ran Inoue, Yoshimi Takata, et al.. (2008). Serine racemase is predominantly localized in neurons in mouse brain. The Journal of Comparative Neurology. 510(6). 641–654. 196 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026